Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.7%

23 terminated/withdrawn out of 1385 trials

Success Rate

91.3%

+4.8% vs industry average

Late-Stage Pipeline

14%

191 trials in Phase 3/4

Results Transparency

4%

10 of 242 completed trials have results

Key Signals

275 recruiting10 with results9 terminated14 withdrawn

Enrollment Performance

Analytics

N/A
347(36.9%)
Phase 2
241(25.6%)
Phase 4
131(13.9%)
Phase 1
84(8.9%)
Early Phase 1
77(8.2%)
Phase 3
60(6.4%)
940Total
N/A(347)
Phase 2(241)
Phase 4(131)
Phase 1(84)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1385)

Showing 20 of 1385 trials
NCT06146946Not ApplicableRecruiting

Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)

Role: collaborator

NCT07650799Not ApplicableNot Yet Recruiting

AI-assisted Rare Disease Diagnosis

Role: lead

NCT07738757Phase 2Not Yet Recruiting

SKB264 Plus KL-A167 in MSI-H/dMMR Advanced Gynecological Malignancies

Role: lead

NCT07738796Not Yet Recruiting

Development and Validation of a Risk Prediction Model for Cardiac Surgery-associated Acute Kidney Injury Based on the Gut-Kidney Axis, Incorporating Gut Microbiota and Their Metabolites

Role: lead

NCT07737249Phase 2Not Yet Recruiting

Efficacy and Safety of Golidocitinib for Rapidly Progressive Interstitial Lung Disease

Role: lead

NCT07737847Not ApplicableNot Yet Recruiting

Clinical Study on ShouTai Pills for Improving Reduced Ovarian Reserve

Role: lead

NCT07324733Not ApplicableRecruiting

Exploring the Novel Value of PSMA PET in Sjögren's Syndrome: Integrated Analysis With Established FAPI PET Imaging

Role: lead

NCT05015348Not ApplicableCompleted

Effect of Omega-3 Supplementation on Fasting Triglycerides During Lifestyle Intervention in Adults With Mild-to-moderate Hypertriglyceridemia

Role: lead

NCT07727681Phase 4Recruiting

Perioperative Statins to Prevent AFib After Lung Surgery

Role: lead

NCT05899725Not ApplicableCompleted

The Efficacy and Safety of Corticosteroids in Combination With Ruxolitinib in the Management of Checkpoint Inhibitor Pneumonia

Role: lead

NCT05599789Phase 2Active Not Recruiting

Pembrolizumab in Combination With Plinabulin and Docetaxel For Metastatic NSCLC After ICIs (KeyPemls-004)

Role: lead

NCT06629818Phase 2Active Not Recruiting

Daratumumab Combined With Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis With Translocation (11;14)

Role: lead

NCT07724197Not Yet Recruiting

Pulsatile Electrical Impedance Tomography for Diagnosis and Monitoring of Acute Pulmonary Embolism

Role: collaborator

NCT07719959Not ApplicableNot Yet Recruiting

A Randomized Controlled Trial of 3D Airway Reconstruction for Precise Double-Lumen Bronchial Intubation

Role: lead

NCT07719140Phase 4Recruiting

Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial)

Role: lead

NCT06215677Phase 2Active Not Recruiting

Neoadjuvant Immunotherapy for T4 dMMR Colon Cancer

Role: lead

NCT07672210Recruiting

PregnAncy-Related Aortic DISsEction in China

Role: collaborator

NCT07707804Not ApplicableNot Yet Recruiting

Bionic Balloon-assisted Delivery Technology on the Labor Process

Role: lead

NCT07466251Phase 4Not Yet Recruiting

PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke

Role: lead

NCT07705204Active Not Recruiting

Adverse Events Among Hospitalized Patients in China

Role: lead